Cost of MS drugs may skyrocket following Medicare rule change


Your substances

None


Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis.

Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.

CONTINUE READING ON www.upi.com

                   

Related News

Loading...